Suppr超能文献

胶质母细胞瘤的细胞系和免疫分类定义了患者的预后。

Cell lines and immune classification of glioblastoma define patient's prognosis.

机构信息

Research Platform in Biological Oncology, Dijon, France.

GIMI Genetic and Immunology Medical Institute, Dijon, France.

出版信息

Br J Cancer. 2019 Apr;120(8):806-814. doi: 10.1038/s41416-019-0404-y. Epub 2019 Mar 22.

Abstract

BACKGROUND

Prognostic markers for glioblastoma are lacking. Both intrinsic tumour characteristics and microenvironment could influence cancer prognostic. The aim of our study was to generate a pure glioblastoma cell lines and immune classification in order to decipher the respective role of glioblastoma cell and microenvironment on prognosis.

METHODS

We worked on two large cohorts of patients suffering from glioblastoma (TCGA, n = 481 and Rembrandt, n = 180) for which clinical data, transcriptomic profiles and outcome were recorded. Transcriptomic profiles of 129 pure glioblastoma cell lines were clustered to generate a glioblastoma cell lines classification. Presence of subtypes of glioblastoma cell lines and immune cells was determined using deconvolution.

RESULTS

Glioblastoma cell lines classification defined three new molecular groups called oncogenic, metabolic and neuronal communication enriched. Neuronal communication-enriched tumours were associated with poor prognosis in both cohorts. Immune cell infiltrate was more frequent in mesenchymal classical classification subgroup and metabolic-enriched tumours. A combination of age, glioblastoma cell lines classification and immune classification could be used to determine patient's outcome in both cohorts.

CONCLUSIONS

Our study shows that glioblastoma-bearing patients can be classified based on their age, glioblastoma cell lines classification and immune classification. The combination of these information improves the capacity to address prognosis.

摘要

背景

胶质母细胞瘤缺乏预后标志物。内在肿瘤特征和微环境都可能影响癌症的预后。我们的研究旨在生成纯胶质母细胞瘤细胞系和免疫分类,以破译胶质母细胞瘤细胞和微环境对预后的各自作用。

方法

我们对两个大型胶质母细胞瘤患者队列(TCGA,n=481 和 Rembrandt,n=180)进行了研究,记录了临床数据、转录组谱和结果。对 129 个纯胶质母细胞瘤细胞系的转录组谱进行聚类,以生成胶质母细胞瘤细胞系分类。使用去卷积确定胶质母细胞瘤细胞系和免疫细胞的亚型存在。

结果

胶质母细胞瘤细胞系分类定义了三个新的分子群,分别称为致癌、代谢和神经元通讯富集群。在两个队列中,神经元通讯富集肿瘤与预后不良相关。间充质经典分类亚组和代谢富集肿瘤中免疫细胞浸润更为频繁。年龄、胶质母细胞瘤细胞系分类和免疫分类的组合可用于确定两个队列中患者的预后。

结论

我们的研究表明,胶质母细胞瘤患者可以根据其年龄、胶质母细胞瘤细胞系分类和免疫分类进行分类。这些信息的组合提高了确定预后的能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2636/6474266/aaed4df0f0fb/41416_2019_404_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验